CDEK
← All drugs Report issue

medi0680

mAbexperimental

Clinical trial activity

3 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Dec 19, 2013 (NCT02013804)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • medi0680

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02271945Phase 1/Phase 2 (Phase 2)Dec 1, 2014MedImmune
NCT02118337Phase 1/Phase 2 (Phase 2)May 19, 2014Brown University, Cornell University, Mayo Clinic, Medical University of South Carolina, MedImmune, Pennsylvania State University, Providence Health & Services, Rutgers University, The Angeles Clinic, University of Oklahoma, University of South Florida, University of Washington, West Virginia University
NCT02013804Phase 1Dec 19, 2013MedImmune
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MedImmuneFor profit3322013
Brown UniversityAcademic/Hospital1012014
Cornell UniversityAcademic/Hospital1012014
Mayo ClinicAcademic/Hospital1012014
Medical University of South CarolinaAcademic/Hospital1012014
Pennsylvania State UniversityAcademic/Hospital1012014
Providence Health & ServicesAcademic/Hospital1012014
Rutgers UniversityAcademic/Hospital1012014
The Angeles ClinicAcademic/Hospital1012014
University of OklahomaAcademic/Hospital1012014
University of South FloridaAcademic/Hospital1012014
University of WashingtonAcademic/Hospital1012014
West Virginia UniversityAcademic/Hospital1012014
13 organizations
Page 1 / 1